高级神经超声与MRI在有脑损伤风险胎儿中的附加价值
这项前瞻性多中心观察研究评估了多平面神经超声和MRI在标准轴位超声基础上诊断高危胎儿脑损伤的附加价值。结果显示多平面神经超声比标准轴位超声和MRI检测到更多胎儿脑室周围回声改变、脑室内出血和基底节/丘脑回声改变,而胎儿MRI未发现神经超声未见的异常。2岁时多数患儿神经发育结局无或轻度损害。
要点
- 多平面神经超声较标准轴位超声和MRI检出更多胎儿脑损伤征象。
- 胎儿MRI未发现神经超声未见的异常,附加价值有限。
- 2岁时多数患儿BSID-III评分在均值1个标准差内。
核心结论
- 在高危胎儿中,多平面神经超声检测到更多脑室周围回声改变、脑室内出血和基底节/丘脑回声改变,优于标准轴位超声和MRI。
- 胎儿MRI未显示神经超声未发现的异常。
- 2岁时多数患儿神经发育结局无或轻度损害。
研究设计与样本
- 前瞻性多中心观察研究,纳入56例有获得性脑异常风险的胎儿,39例具备所有胎儿影像学检查。
- 产前每两周行轴位超声和多平面神经超声,MRI一次;生后行新生儿颅脑超声和MRI。
- 由不知晓其他影像结果的专家小组评估影像,随访至2岁用Touwen检查、Alberta婴儿运动量表、BSID-III及行为、感觉和语言问卷。
主要发现
- 脑室周围回声/信号改变:轴位超声6/39,多平面神经超声21/39,MRI 2/39。
- 脑室内出血:轴位超声3/39,多平面神经超声11/39,MRI 1/39。
- 基底节/丘脑回声/信号改变:轴位超声0/39,多平面神经超声12/39,MRI 0/39。
- 1岁时13/46例婴儿结局可疑神经发育后遗症;2岁时41/41例BSID-III评分在均值1个标准差内,20例在行为(5/38)、感觉(17/37)和/或语言(6/39)问卷中评分低于均值1个标准差以上。
临床怎么用
- 对有脑损伤风险的胎儿,可考虑使用多平面神经超声以提高获得性脑异常的检出。
- 胎儿MRI不应常规用于替代神经超声检测这些异常。
局限性
- 仅39/56例胎儿具备所有胎儿影像学检查。
- 队列中脑异常严重程度有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the additional value of fetal multiplanar (axial, coronal and sagittal) neurosonography and magnetic resonance imaging (MRI) to that of the standard axial ultrasound planes in diagnosing brain damage in fetuses at high risk. METHODS: This was a prospective, multicenter, observational study. Women were eligible for participation if their fetus was at risk for acquired brain anomalies. Risk factors were congenital infection, alloimmune thrombocytopenia, fetal growth restriction, trauma during pregnancy, fetal hydrops, monochorionic twins and prior ultrasound finding suggestive of an acquired brain anomaly. Examinations of the fetal brain before birth comprised axial ultrasound and advanced neurosonography biweekly and MRI once. After birth, neonatal cranial ultrasound was performed at < 24 h and at term-equivalent age. Neonatal brain MRI was performed once at term-equivalent age. An expert panel blinded to medical information, including imaging findings by the other methods, evaluated the presence of periventricular echogenicity (PVE) changes, peri- and intraventricular hemorrhage (IVH) and changes in basal ganglia and/or thalami echogenicity (BGTE) on ultrasound, and the equivalent signal intensity (SI) changes on MRI. Conclusions on imaging findings were generated by consensus. The children were followed up with examinations for psychomotor development at 1 year of age, using the Touwen examination and Alberta Infant Motor Scale, and at 2 years of age using Bayley Scale of Infant Development-III (BSID-III) and behavioral, sensory profile and linguistic questionnaires; scores > 1 SD below the mean were considered suspicious for neurodevelopmental sequelae. RESULTS: Fifty-six fetuses were examined, and in 39/56 fetuses, all fetal-imaging modalities were available. PVE/SI changes were observed in 6/39, 21/39 and 2/39 fetuses on axial ultrasound planes, multiplanar neurosonography and MRI, respectively. IVH was found in 3/39, 11/39 and 1/39 fetuses, and BGTE/SI changes in 0/39, 12/39 and 0/39 fetuses, respectively. Outcome was suspicious for neurodevelopmental sequelae in 13/46 infants at 1 year, and at 2 years, 41/41 children had scores within 1 SD of the mean on BSID-III and 20 had scores > 1 SD below the mean on the behavioral (5/38), sensory profile (17/37) and/or linguistic (6/39) questionnaires. CONCLUSIONS: In this cohort of fetuses at risk for brain damage, the severity of acquired brain anomalies was limited. Nevertheless, multiplanar neurosonography detected more fetal PVE changes, IVH and/or BGTE changes compared to the standard axial ultrasound planes and MRI. Fetal MRI did not demonstrate any anomalies that were not seen on neurosonography. Neurodevelopmental outcome at 2 years of age showed no or mild impairment in most cases. © 2019 Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
引用
- van der Knoop BJ, Zonnenberg IA, Verbeke JIML, et al. Additional value of advanced neurosonography and magnetic resonance imaging in fetuses at risk for brain damage. Ultrasound Obstet Gynecol. 2020. PMID: 31828836. doi:10.1002/uog.21943
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。